Want to submit your event or news story?

Use our contact form to send your information and someone will get back to you as soon as possible.

Contact Us

Department News

2021 Admitted Student Visit Days Events

Graduate students admitted to the UW Department of  Global Health are invited to join department faculty, students and staff in March to learn more about the department's graduate programs, life in Seattle, and becoming a part of the UW global health community. Admitted students interact with DGH faculty, current students, and alumni and discuss their experiences in global health research, learning, service and career paths.

Four Visit Days events are open to DGH current students as well as 2021 admitted students:

Global Healthies Student Opportunities Fair, Jan. 25 - Feb. 5

UW Global Health students: DGH faculty and staff want to collaborate with YOU! Gain first-hand experience on global health projects!

Below are current and upcoming projects from DGH researchers and staff who are looking for students to get involved! DGH will hold networking sessions between January 25 and February 5 where students can discuss project opportunities with relevant faculty/staff.

In the Media

New COVID-19 In-Depth Report: Summary of SARS-CoV-2 Novel Variants

At just over one year into the COVID-19 pandemic, evolution of SARS-CoV-2 has generated viral variants that differ in their genetic sequence from the strain first detected in December 2019. Evidence is emerging about how these variants differ in their transmission characteristics, associated clinical symptoms, and vaccine efficacy. This document is a brief summary of published evidence about characteristics of SARS-CoV-2 variants that may impact the public health response, including transmission and response to vaccination.

United World Antiviral Research Network (UWARN) Partners Collaborate to Expand Understanding of New COVID Variants, Key to Future Vaccine Development

The recent recognition of new COVID-19 variants, first detected in South Africa (B.1.135, 501Y.V2), Brazil (P1) and the UK (B.1.1.7) – and the variants’ potential to disrupt vaccine effectiveness and protection from prior COVID-19 infection – is an urgent concern that UWARN partners around the globe are collaborating on to understand.